Dr. Azarani has over 25 years of Life & Health Sciences experience spanning the Academic, Government and Private Institutions. She has extensive scientific, technical and market knowledge in life sciences (biotechnology and pharmaceutical industry) and health care (hospitals, medical offices, and health care facilities) fields.
Dr. Azarani has comprehensive experience in business development, tactical/strategic marketing, R&D, product development, applications development, technology evaluation & scouting, strategic partnership, licensing, M&A, patent review, intellectual property, international sales, and health care innovations and management.
Dr. Azarani has many years of experience in building different departments and high performance cross-functional teams in multi-site operations. She has extensive experience in identifying and prioritizing resources necessary to execute plans, track performance and make reallocation decisions to maintain or improve the productivity of all departments and return on activities. She has driven innovation and revenue growth by diversifying product portfolio and developing many new business opportunities, strategic partnerships, co-marketing, licensing, OEMs, acquisitions, and joint ventures. Many of the companies she has worked for have sold for millions of dollars.
Dr. Azarani’s specific areas of life sciences expertise are in the fields of physiology, biology, molecular biology, chemistry,biochemistry, genetics and proteomics. She has extensive experience in the areas of high-throughput automation technology/instrumentations, consumables (plastic and reagents), microfluidics, software & databases, assay development & miniaturization, genetic mapping/expression/analysis, sequencing, next generation sequencing technology, immunohistochemistry, protein chemistry/trafficking/sorting/analysis, crystallography, metalloproteases biochemistry, membrane biology, receptors, microarray production and technology, hormone regulation, drug discovery, and pharmacology .
Dr. Azarani is a Scientific Reviewer for JALA (Journal of the Association for Laboratory Automation).
EDUCATIONAL HISTORY
LIFE SCIENCES: Dr. Azarani has received her Ph.D. in Physiology from McGill University/Royal Victoria Hospital/Shriners Hospital (Canada), and postdoctoral degrees in Biochemistry & Molecular Biology from University of Montreal (Canada) in collaboration with Roche Pharmaceuticals, and in Genetics from Stanford University/Howard Hughes Medical Institute (California). She has a B. S. in Chemistry/Biochemistry form Concordia University/Co-Operative Education (Canada). She has a Project Management certificate by CADENCE Management Corporation.
HEATLH SCIENCES:
Dr. Azarani has an Executive Health Care Innovation Management certificate from Stanford School of Professional Development and a Medical Office Manager certificate (Medical Coding ICD/CPT, Medical Billing, healthcare management) from Meditec.
Dr. Azarani is fluent in English and French
GROUPS & ASSOCIATIONS
PUBLICATIONS
Dr. Azarani has over 100 peer reviewed scientific publications, abstracts, presentations, and many issued patents. She is a reviewer for the Journal of the Association for Laboratory Automation (JALA). Examples are:
PATENTS
APLLICATIONS DEVELOPED IN LIFE SCIENCES FILED
A few of the applications developed by Dr. Azarani are:
Dr. Azarani has comprehensive experience in business development, tactical/strategic marketing, R&D, product development, applications development, technology evaluation & scouting, strategic partnership, licensing, M&A, patent review, intellectual property, international sales, and health care innovations and management.
Dr. Azarani has many years of experience in building different departments and high performance cross-functional teams in multi-site operations. She has extensive experience in identifying and prioritizing resources necessary to execute plans, track performance and make reallocation decisions to maintain or improve the productivity of all departments and return on activities. She has driven innovation and revenue growth by diversifying product portfolio and developing many new business opportunities, strategic partnerships, co-marketing, licensing, OEMs, acquisitions, and joint ventures. Many of the companies she has worked for have sold for millions of dollars.
Dr. Azarani’s specific areas of life sciences expertise are in the fields of physiology, biology, molecular biology, chemistry,biochemistry, genetics and proteomics. She has extensive experience in the areas of high-throughput automation technology/instrumentations, consumables (plastic and reagents), microfluidics, software & databases, assay development & miniaturization, genetic mapping/expression/analysis, sequencing, next generation sequencing technology, immunohistochemistry, protein chemistry/trafficking/sorting/analysis, crystallography, metalloproteases biochemistry, membrane biology, receptors, microarray production and technology, hormone regulation, drug discovery, and pharmacology .
Dr. Azarani is a Scientific Reviewer for JALA (Journal of the Association for Laboratory Automation).
EDUCATIONAL HISTORY
LIFE SCIENCES: Dr. Azarani has received her Ph.D. in Physiology from McGill University/Royal Victoria Hospital/Shriners Hospital (Canada), and postdoctoral degrees in Biochemistry & Molecular Biology from University of Montreal (Canada) in collaboration with Roche Pharmaceuticals, and in Genetics from Stanford University/Howard Hughes Medical Institute (California). She has a B. S. in Chemistry/Biochemistry form Concordia University/Co-Operative Education (Canada). She has a Project Management certificate by CADENCE Management Corporation.
HEATLH SCIENCES:
Dr. Azarani has an Executive Health Care Innovation Management certificate from Stanford School of Professional Development and a Medical Office Manager certificate (Medical Coding ICD/CPT, Medical Billing, healthcare management) from Meditec.
Dr. Azarani is fluent in English and French
GROUPS & ASSOCIATIONS
- Biotech & Pharma Professionals Network
- The Global Business Development Network
- Business Analysts Globally
- Global Executive Exchange
- Executive Suite
- Genomics and Proteomics
- Genomics-Next Generation DNA-Sequencing & Microarray
- Cell and Molecular Biology
- Laboratory Robotics Interest Group (LRIG)
- Liquid Handling Robotics
- Society for Biomolecular Sciences
- Analytical Instruments Professional Network
- Chromatography and Spectroscopy Exchange
- Medical Device R & D, Regulatory and Quality Connections
- Structural Biology
- Imaging and Optics
- BayBio
- Bay Area Health Care Entrepreneurs
- Startups and Entrepreneurs Get Funded
- California Expert Witnesses
- California Biotech & Pharma Network
- Biotech Investment Group
- Expert Witness Network
- Friends of the Forensic Expert Witness
- Stanford University Alumni
- Stanford University Medical Center Alumni
- McGill University Alumni
- Contract Manufacturing-Medical Devices
- Healthcare TGL
- Innovation Center Denmark Silicon Valley
- Professionals in the Pharmaceutical & Biotech Industry
- SVForum
- Senior Executive Exchange
- Startups & Entrepreneurs Get Funded
- The Life Sciences Executive Exchange
PUBLICATIONS
Dr. Azarani has over 100 peer reviewed scientific publications, abstracts, presentations, and many issued patents. She is a reviewer for the Journal of the Association for Laboratory Automation (JALA). Examples are:
- Mouse Attractin homologs show functional compensation without redundancy, Genesis, 45 (12):744-756, 2007
- High Throughput Protein Crystallography, JALA, 11: 7-15, 2006
- Endometriosis: Insights into its pathogenesis and treatment, Surgical Technology International 12:178-81, 2004
- Automated High-Throughput Protein Crystallization by the Use of Precision Glass Syringes, Non-contact Microsolenoid Dispensers, and Screening Plates, Proteomics handbook, Humana Press, Chapter 27, 2004
- The use of precision glass syringes and a noncontact microsolenoid dispenser for the production of high-throughput low-density arrays, Methods Mol Biol,264:145-59, 2004
- DNA Sequencing Automation with the Rolling Circle Amplification Procedure Using Precision Glass Syringes in High Throughput Liquid Handling Systems; 40-fold Reduction in Amplification Reaction Volumes, BioTechniques 34:204-207, 2003
- High Throughput RNA Purification with Ambion RNAqueous Kits on the Apogent Discoveries Tango Liquid Handling System, Genomics and Proteomics 3:51, 2003
- The Use of Precision Glass Syringes and a Non-Contact Microsolenoid Dispenser for the Production of High Throughput Low Density Arrays, Protein Arrays, Humana Press, Chapter 13, 2003
- Setting Up High-Throughput, Low-Volume Sequencing and PCR Reactions Using an Automated System Equipped with Precision Glass Syringes and a Non-Contact Microsolenoid Dispenser, JALA 8:37-40, 2003
- PCR Purification with the Whatman® 96-well PCR Cleanup Kit on the Apogent Discoveries Hydra® and TangoTM Liquid Handling Systems, American Biotechnology Laboratory 21:16-18, 2003
- High-Throughput Electrophoresis, JALA 8:28-30, 2003
- A Study of a High-Throughput Plasmid DNA Purification System, JALA 8:36-39, 2003
- Identification and preliminary characterization of mouse Adam33, BMC Genetics 3: 2, 2002
- High-throughput electrophoresis using automated liquid handling microdispensers, American Biotechnology Laboratory 20: 38, 2002
- High Throughput Plasmid DNA purification Using Precision Glass Syringes, Genomics and Proteomics 2:51, 2002
- The High-speed Hydra®-Plus-One System for Automated High-Throughput Protein Crystallography, Acta Cryst. D58:1523-1526, 2002
- RNA Fractionation by Ion-Pair Reversed Phase High Performance Liquid Chromatography for the construction of larger-size insert cDNA libraries, submitted, 2002
- Array production using the Hydra microdispenser and the Tango Liquid handling system, BioTechniques 32:1360-65, 2002
- RNA analysis by Ion-Pair Reversed Phase High Performance Liquid Chromatography, Nucleic Acid Research 29, No. 2 e7, 2001
- RNA analysis by ion-pair reversed-phase HPLC, Nature Biotechnology Volume II, 29, 2000
- The mouse mahogany locus encodes a transmembrane form of human attractin. Nature 398:152-6, 1999
- Recombinant human endothelin-converting enzyme ECE-1b is located in an intracellular compartment when expressed in polarized Madin-Darby Canine Kidney cells, Biochemical Journals 333:439-448, 1998
- Structurally Diverse N-Terminal Peptides of parathyroid hormone (PTH)/PTH-related peptide (PTHRP) Inhibit the Na+/H+ exchanger NHE-3 Isoform by Binding to a Single PTH/PTHRP Receptor (type I) and Activating Distinct Signaling Pathways, Journal of Biological Chemistry 271:14931-14936, 1996
- Parathyroid Hormone and Parathyroid Hormone-Related Peptide activate the Na+/H+ exchanger NHE-1 isoform in osteoblastic cells (UMR-106) via a cAMP-dependent pathway, Journal of Biological Chemistry 270: 23166-23172, 1995.
- Parathyroid hormone and Parathyroid Hormone-Related peptide inhibit the apical Na+/H+ exchanger NHE-3 isoform in renal cells (OK) via a dual signaling cascade involving protein kinase A and C, Journal of Biological Chemistry 270: 20004-20010, 1995.
- PTH and PTHRP inhibit the NHE3 isoform of the Na+/H+ exchanger in renal cells (OK) via a dual signaling cascade involving protein kinase A and C, J. Bone and Mineral Res. 10: S286, 1995
- Parathyroid hormone and Parathyroid Hormone Related Peptide activate Na+/H+ exchange in osteoblastic cells (UMR-106) via a cyclic AMP dependent pathway, J. Bone and Mineral Res. 9:S169, 1994
- Activation of HEK cells adenylate cyclase by PTH and PTHRP, J. Bone and Mineral Res.17:121, 1992
- Activation of Adenylate cyclase by PTH and PTHRP in human embryonic kidney cells, Medecine Sciences, (French) 17: 8:14, 1992
- Electron transfer reactions between excited diarylmethyl and triarylmethyl carbocations and aromatic donors, J. Photochem. 175-189, 1991
- Diffuse Reflectance Laser Flash Photolysis studies of reactions of triplet Benzophenone with hydrogen donors on Silica, J. of Physical Chem. 95:4430-4435, 1991
PATENTS
- Provisional Patent entitled Personal Document Scanner, Sorter, Categorizer, and Organizational Software, 2003.
- Patent Application No. WO00181566 entitled APPARATUS AND METHOD FOR SEPARATING AND PURIFYING POLYNUCLEOTIDES.
- U.S Patent Application No. US6521411 entitled METHOD AND SYSTEM FOR THE PREPARATION OF cDNA.
- Patent Application No. WO0166218 entitled CHROMATOGRAPHIC METHOD FOR RNA STABILIZATION.
- U.S. Patent Application No. US20020620 entitled METHOD AND SYSTEM FOR PURIFICATION AND QUALITY ANALYSIS OF RNA.
- U.S. Patent Application No. US20020102563 entitled APRATUS AND METHODS FOR SEPARATING AND PURIFYING NUCLEOTIDES.
- U.S Patent Application No. US2001000808447 entitled METHOD AND SYSTEM FOR PREPARATION OF cDNA.
- U.S Patent Application No. US20010051715 entitled CHROMATOGRAPHIC METHOD FOR RNA STABILIZATION.
- U.S. Provisional Application entitled LOW VOLUME MICRO-PLATE AND VOLUME-LIMITING PLUGS. Reference number 60435-301600.
- U.S. Provisional Application entitled PERSONAL Document scanner, Sorter, Categorizer, and organizational software.
APLLICATIONS DEVELOPED IN LIFE SCIENCES FILED
A few of the applications developed by Dr. Azarani are:
- Automated High-Throughput Microdrop Crystallization Using Corning CrystalEX 96 Well Protein Crystallization Microplates
- DNA Sequencing Automation with the Rolling Circle Amplification Procedure Using Precision Glass Syringes in High Throughput Liquid Handling Systems; 40-fold Reduction in Amplification Reaction Volumes.
- High Throughput RNA Purification with Ambion RNAqueous Kits on the Apogent Discoveries Tango Liquid Handling System
- The Use of Precision Glass Syringes and a Non-Contact Microsolenoid Dispenser for the Production of High Throughput Low Density Arrays
- Setting Up High-Throughput, Low-Volume Sequencing and PCR Reactions Using an Automated System Equipped with Precision Glass Syringes and a Non-Contact Microsolenoid Dispenser
- PCR Purification with the Whatman® 96-well PCR Cleanup Kit on the Apogent Discoveries Hydra® and TangoTM Liquid Handling Systems
- High-Throughput Electrophoresis Using the Robbins® TangoTM Automated Liquid Handling System and the InvitrogenTM E-Gel® 96 system
- High Throughput Plasmid DNA Purification with the Millipore Montágeä Plasmid Miniprep96 Kit on the Apogent Discoveries PlateMate Plusâ and Tangoä Liquid Handlers
- High-throughput electrophoresis using automated liquid handling microdispensers
- High Throughput Plasmid DNA purification Using Precision Glass Syringes
- High-speed Hydra®-Plus-One System for Automated High-Throughput Protein Crystallography
- Array production using the Hydra microdispenser and the Tango Liquid handling system
- RNA Fractionation by Ion-Pair Reversed Phase High Performance Liquid Chromatography for the construction of larger-size insert cDNA libraries
- RNA analysis by Ion-Pair Reversed Phase High Performance Liquid Chromatography
Our services and solutions enhance your productivity, performance, precision and throughput